Otsuka Holdings
4578.T
#664
Rank
HK$311.23 B
Marketcap
HK$592.39
Share price
-3.26%
Change (1 day)
41.20%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

Earnings for Otsuka Holdings (4578.T)

Earnings in 2023: HK$8.24 Billion

According to Otsuka Holdings 's latest financial reports the company's current earnings are HK$14.47 Billion. In 2023 the company made an earning of HK$8.24 Billion a decrease over its 2022 earnings that were of HK$10.43 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Otsuka Holdings from 2010 to 2023

Annual earnings

Year Earnings Change
2023HK$8.24 B-20.93%
2022HK$10.43 B-12.7%
2021HK$11.95 B-19.92%
2020HK$14.92 B13.9%
2019HK$13.10 B52.07%
2018HK$8.61 B11.22%
2017HK$7.74 B-36.03%
2016HK$12.11 B31.15%
2015HK$9.23 B
2013HK$19.16 B33.52%
2012HK$14.35 B-4.65%
2011HK$15.05 B45.53%
2010HK$10.34 B